# Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee

> **NCT01688934** · PHASE2 · COMPLETED · sponsor: **Purdue Pharma LP** · enrollment: 230 (actual)

## Conditions studied

- Osteoarthritis, Knee
- Pain

## Interventions

- **DRUG:** V116517 50-mg tablets
- **DRUG:** V116517 30-mg tablets
- **DRUG:** Naproxen 500-mg capsules
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01688934
- **Lead sponsor:** Purdue Pharma LP
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-06
- **Final completion:** 2013-08
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2013-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688934, "Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis (OA) of the Knee". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01688934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*